3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Recurrence
1
Hepatitis C
1
Carcinoma, Hepatocellular
1
Interventions
Ribavirin
4
ledipasvir, sofosbuvir drug combination
2
Chromatography, High Pressure Liquid
2
tremelimumab
1
telaprevir
1
sofosbuvir-velpatasvir drug combination
1
pembrolizumab
1
peginterferon alfa-2a
1
ledipasvir
1
grazoprevir
1
elbasvir-grazoprevir drug combination
1
elbasvir
1
Sofosbuvir
1
Rapid Diagnostic Tests
1
Patient Navigation
1
Introns
1
Infliximab
1
Immunoenzyme Techniques
1
Hypothermia, Induced
1
Enzyme-Linked Immunosorbent Assay
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatitis C
×
sofosbuvir-velpatasvir drug combination
×
Clear all
NCT04653818
2023-04-04
RCT
Alexandria University
Phase 4
Completed
84 enrolled